{
  "issued_date": "2013-08-14", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON303150", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2013/064", 
    "Audience": "Healthcare professional", 
    "Published": "14 August 2013 at 14:30", 
    "Format": "Electronic", 
    "Size": "A4", 
    "Pages": "5", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "image/jpeg", 
      "title": "Home use blood glucose test strips", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/CON305470.jpg", 
      "filename": "downloads/35e8a414241c5e427d3265e047c5c74c9a494c66/CON305470.jpg", 
      "original_filename": "CON305470.jpg"
    }
  ], 
  "body": "## Device\n\n![ASSET_TAG](#ASSET0)Home use blood glucose test strips\n\nGlucoMen LX Sensor blood glucose test strips 50 count (product code 38877), used with the GlucoMen LX and GlucoMen LX PLUS meter manufactured by Menarini. Lot 3212214249, expiry date 31-08-2014 and lot 3212219249, expiry date 31-08-2014.\n\nIllustration of tub, containing 50 test strips.\n\n## Problem\n\nAffected lots have been contaminated during manufacture, and may give an overestimation of blood glucose levels, potentially resulting in inappropriate insulin administration.\n\nThe manufacturer distributed the affected lots in the UK via wholesale outlets during October and November 2012. The product may, however, still remain with users or pharmacies.\n\nThere is currently no evidence that UK patients have been affected.\n\n## Action  \n  \n  * Identify and quarantine affected lots.  \n  * Identify patients using these meters and advise them that they should return and not use strips from the affected lots.  \n  * Ensure that users who return strips from the affected lots can continue to monitor their blood glucose.  \n  * Contact Menarini to arrange the return of any strips from the affected lots.  \n  \n### Action by\n\nHealthcare personnel managing patients who use these devices.\n\n## Distribution\n\nThis MDA has been sent to: \u00a0  \n  \n  * Care Quality Commission (CQC) (headquarters) for information  \n  * Clinical commissioning groups (CCGs)  \n  * Directors of public health  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * Local authorities in Scotland (equipment coordinators)  \n  * NHS boards and trusts in Wales (chief executives)  \n  * NHS boards in Scotland (equipment coordinators)  \n  * NHS England area teams  \n  * NHS trusts in England (chief executives)  \n  * OFSTED (directors of children\u2019s services) for information  \n  * Public Health England (for information)  \n  * Social services in England (directors)  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment.\u00a0  \nBelow is a suggested list of recipients. \u00a0\n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * Ambulance services directors  \n  * Ambulance staff  \n  * Chief pharmacists  \n  * Clinical biochemistry leads  \n  * Clinical governance leads  \n  * Community children\u2019s nurses  \n  * Community diabetes specialist nurses  \n  * Community nurses  \n  * Community Pharmacies  \n  * Consultant Clinical Biochemists  \n  * Diabetes clinics/outpatients  \n  * Diabetes nurse specialists  \n  * Diabetes, directors of  \n  * District nurses  \n  * Health and safety managers  \n  * Health visitors  \n  * Hospital at home units  \n  * Hospital pharmacies  \n  * Hospital pharmacists  \n  * Medical directors  \n  * Minor injury units  \n  * NHS walk-in centres  \n  * Paediatrics departments  \n  * Paramedics  \n  * Pathology Directors  \n  * Pharmaceutical advisors  \n  * Pharmacists  \n  * Point Of Care Testing Managers  \n  * Purchasing managers  \n  * Risk managers  \n  * School nurses  \n  * Supplies managers  \n  * Walk-in centres  \n  \nPublic Health England  \nDirectors for onward distribution to:  \n  \n  * Risk manager  \n  * Safety officers  \n  \nNHS England area teams  \nCAS liaison officers for onward distribution to all relevant staff including:  \n  \n  * Community pharmacists  \n  * General practitioners  \n  * Practice managers  \n  * Practice nurses  \n  \nSocial services  \nLiaison officers for onward distribution to all relevant staff including:  \n  \n  * Care at home staff  \n  * Care management team managers  \n  * Children\u2019s disability services  \n  * Community care staff  \n  * Day centres (older people, learning disabilities, mental health, physical disabilities, respite care, autistic services)  \n  * Directors of public health  \n  * In-house residential care homes  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \nThis alert should be read by:  \n  \n  * Adult placement  \n  * Care homes providing nursing care (adults)  \n  * Care homes providing personal care (adults)  \n  * Clinics  \n  * Domiciliary care providers  \n  * Further education colleges registered as care homes  \n  * Hospices  \n  * Hospitals in the independent sector  \n  * Independent treatment centres  \n  * Nursing agencies  \n  * Private medical practitioners  \n  \nEstablishments registered with OFSTED  \nThis alert should be read by:  \n  \n  * Children\u2019s services  \n  * Educational establishments with beds for children  \n  * Residential special schools  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health\u2019s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk)\u00a0and requesting this facility.\n\n## Manufacturer Contact\n\nManufacturer  \nTony Jones  \nA.Menarini Diagnostics  \nWharfedale Road  \nWinnersh  \nWokingham  \nBerkshire  \nRG41 5RA\n\nTel:\u00a0\u00a0\u00a0 0118 944 4100  \nEmail: \u00a0\u00a0 [tony.jones@menarinidiag.co.uk](mailto:tony.jones@menarinidiag.co.uk)\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk).\n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2013/064 or 2013/007/019/081/020\n\nTechnical aspects  \nBina Mackenzie or Anthony Llewellyn\n\nMedicines & Healthcare Products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0\u00a0\u00a0 020 3080 7229 / 6792  \nFax:\u00a0 020 8754 3965  \nEmail:\u00a0\u00a0\u00a0 [bina.mackenzie@mhra.gsi.gov.uk](mailto:bina.mackenzie@mhra.gsi.gov.uk) or [anthony.llewellyn@mhra.gsi.gov.uk](mailto:anthony.llewellyn@mhra.gsi.gov.uk)\n\nClinical aspects  \nFor clinical aspects please contact the clinical team.\n\nMedicines & Healthcare Products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0\u00a0\u00a0 020 3080 7032 / 7248  \nFax:\u00a0 020 8754 3965\n\n### How to report adverse incidents\n\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found [on the CAS website](https://www.cas.dh.gov.uk/Home.aspx) (external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald BT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link)  \nFurther information about SABS can be found [on the SABS website](http://sabs.dhsspsni.gov.uk/)(external link)\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\n[Incident Reporting and Investigation Centre](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/)  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 3922  \nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><img src=\"#ASSET0\" alt=\"ASSET_TAG\"><span>Home use blood glucose test strips</span></p>\n\n<p><span>GlucoMen LX Sensor blood glucose test strips 50 count (product code 38877), used with the GlucoMen LX and GlucoMen LX PLUS meter manufactured by Menarini. Lot 3212214249, expiry date 31-08-2014 and lot 3212219249, expiry date 31-08-2014.</span></p>\n\n<p>Illustration of tub, containing 50 test strips.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p>Affected lots have been contaminated during manufacture, and may give an overestimation of blood glucose levels, potentially resulting in inappropriate insulin administration.</p>\n\n<p>The manufacturer distributed the affected lots in the UK via wholesale outlets during October and November 2012. The product may, however, still remain with users or pharmacies.</p>\n\n<p>There is currently no evidence that UK patients have been affected.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<ul>\n<li>Identify and quarantine affected lots.</li>\n\n<li>Identify patients using these meters and advise them that they should return and not use strips from the affected lots.</li>\n\n<li>Ensure that users who return strips from the affected lots can continue to monitor their blood glucose.</li>\n\n<li>Contact Menarini to arrange the return of any strips from the affected lots.</li>\n</ul>\n\n<h3>Action by</h3>\n\n<p>Healthcare personnel managing patients who use these devices.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to: <span>&#160;</span></p>\n\n<ul>\n<li>Care Quality Commission (CQC) (headquarters) for information</li>\n\n<li>Clinical commissioning groups (CCGs)</li>\n\n<li>Directors of public health</li>\n\n<li>HSC trusts in Northern Ireland (chief executives)</li>\n\n<li>Local authorities in Scotland (equipment coordinators)</li>\n\n<li>NHS boards and trusts in Wales (chief executives)</li>\n\n<li>NHS boards in Scotland (equipment coordinators)</li>\n\n<li>NHS England area teams</li>\n\n<li>NHS trusts in England (chief executives)</li>\n\n<li>OFSTED (directors of children&#8217;s services) for information</li>\n\n<li>Public Health England (for information)</li>\n\n<li>Social services in England (directors)</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment.&#160;<br>\nBelow is a suggested list of recipients. &#160;</p>\n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Ambulance services directors</li>\n\n<li>Ambulance staff</li>\n\n<li>Chief pharmacists</li>\n\n<li>Clinical biochemistry leads</li>\n\n<li>Clinical governance leads</li>\n\n<li>Community children&#8217;s nurses</li>\n\n<li>Community diabetes specialist nurses</li>\n\n<li>Community nurses</li>\n\n<li>Community Pharmacies</li>\n\n<li>Consultant Clinical Biochemists</li>\n\n<li>Diabetes clinics/outpatients</li>\n\n<li>Diabetes nurse specialists</li>\n\n<li>Diabetes, directors of</li>\n\n<li>District nurses</li>\n\n<li>Health and safety managers</li>\n\n<li>Health visitors</li>\n\n<li>Hospital at home units</li>\n\n<li>Hospital pharmacies</li>\n\n<li>Hospital pharmacists</li>\n\n<li>Medical directors</li>\n\n<li>Minor injury units</li>\n\n<li>NHS walk-in centres</li>\n\n<li>Paediatrics departments</li>\n\n<li>Paramedics</li>\n\n<li>Pathology Directors</li>\n\n<li>Pharmaceutical advisors</li>\n\n<li>Pharmacists</li>\n\n<li>Point Of Care Testing Managers</li>\n\n<li>Purchasing managers</li>\n\n<li>Risk managers</li>\n\n<li>School nurses</li>\n\n<li>Supplies managers</li>\n\n<li>Walk-in centres</li>\n</ul>\n\n<p><span>Public Health England</span><br>\nDirectors for onward distribution to:</p>\n\n<ul>\n<li>Risk manager</li>\n\n<li>Safety officers</li>\n</ul>\n\n<p><span>NHS England area teams</span><br>\nCAS liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Community pharmacists</li>\n\n<li>General practitioners</li>\n\n<li>Practice managers</li>\n\n<li>Practice nurses</li>\n</ul>\n\n<p><span>Social services</span><br>\nLiaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Care at home staff</li>\n\n<li>Care management team managers</li>\n\n<li>Children&#8217;s disability services</li>\n\n<li>Community care staff</li>\n\n<li>Day centres (older people, learning disabilities, mental health, physical disabilities, respite care, autistic services)</li>\n\n<li>Directors of public health</li>\n\n<li>In-house residential care homes</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p><span>Establishments registered with the Care Quality Commission (CQC) (England only)</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Adult placement</li>\n\n<li>Care homes providing nursing care (adults)</li>\n\n<li>Care homes providing personal care (adults)</li>\n\n<li>Clinics</li>\n\n<li>Domiciliary care providers</li>\n\n<li>Further education colleges registered as care homes</li>\n\n<li>Hospices</li>\n\n<li>Hospitals in the independent sector</li>\n\n<li>Independent treatment centres</li>\n\n<li>Nursing agencies</li>\n\n<li>Private medical practitioners</li>\n</ul>\n\n<p><span>Establishments registered with OFSTED</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Children&#8217;s services</li>\n\n<li>Educational establishments with beds for children</li>\n\n<li>Residential special schools</li>\n</ul>\n\n<p>Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health&#8217;s Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\" added=\"null\">safetyalerts@dh.gsi.gov.uk</a>&#160;and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\t<p><span>Manufacturer</span><br>\nTony Jones<br>\nA.Menarini Diagnostics<br>\nWharfedale Road<br>\nWinnersh<br>\nWokingham<br>\nBerkshire<br>\nRG41 5RA</p>\n\n<p>Tel:&#160;&#160;&#160; 0118 944 4100<br>\nEmail: &#160;&#160; <a href=\"mailto:tony.jones@menarinidiag.co.uk\">tony.jones@menarinidiag.co.uk</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\" added=\"null\">dts@mhra.gsi.gov.uk</a>.</p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2013/064</span> or <span>2013/007/019/081/020</span></p>\n\n<p><span>Technical aspects</span><br>\nBina Mackenzie or Anthony Llewellyn</p>\n\n<p>Medicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;&#160;&#160; 020 3080 7229 / 6792<br>\nFax:&#160; 020 8754 3965<br>\nEmail:&#160;&#160;&#160; <a href=\"mailto:bina.mackenzie@mhra.gsi.gov.uk\">bina.mackenzie@mhra.gsi.gov.uk</a> or <a href=\"mailto:anthony.llewellyn@mhra.gsi.gov.uk\">anthony.llewellyn@mhra.gsi.gov.uk</a></p>\n\n<p><span>Clinical aspects</span><br>\nFor clinical aspects please contact the clinical team.</p>\n\n<p>Medicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;&#160;&#160; 020 3080 7032 / 7248<br>\nFax:&#160; 020 8754 3965</p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings<br>\nStormont Estate<br>\nDundonald BT4 3SQ</p>\n\n<p>Tel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\" added=\"null\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a> (external link)<br>\nFurther information about SABS can be found <a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\" added=\"null\">Incident Reporting and Investigation Centre</a><br>\nHealth Facilities Scotland<br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB</p>\n\n<p>Tel: 0131 275 7575<br>\nFax: 0131 314 0722</p>\n\n<p>Email: <a href=\"mailto:nss.iric@nhs.net\" added=\"null\">nss.iric@nhs.net</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 3922<br>\nEmail: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: GlucoMen LX Sensor blood glucose test strips manufactured by Menarini (MDA/2013/064)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": [
    "care-home-staff", 
    "general-practice", 
    "pharmacy"
  ]
}